OP2 Nab-paclitaxel in the treatment of advanced pancreatic cancer refractory to gemcitabine - Final results of a phase 2 trial

G.de Lima Lopes; P.Hosein; C.Gomez; V.Pastorini; J.Macintyre; M.Easey; I.Reis; J.Merchan; P.Bejarano; C.Rocha-Lima

首页> 外文期刊>European Journal of Cancer Supplements >OP2 Nab-paclitaxel in the treatment of advanced pancreatic cancer refractory to gemcitabine - Final results of a phase 2 trial

【24h】

OP2 Nab-paclitaxel in the treatment of advanced pancreatic cancer refractory to gemcitabine - Final results of a phase 2 trial

机译：OP2 Nab-紫杉醇治疗难治性吉西他滨的晚期胰腺癌-2期试验的最终结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2011年第1期|共1页
作者
G.de Lima Lopes; P.Hosein; C.Gomez; V.Pastorini; J.Macintyre; M.Easey; I.Reis; J.Merchan; P.Bejarano; C.Rocha-Lima;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer [J] . Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, Investigational new drugs. . 2019,第3期

机译：酶1试验对吉拉甲醛与吉西他滨和Nab-紫杉醇组合治疗晚期胰腺癌
2. PANOVA-3: A phase III trial of TTFields with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma [J] . Weinberg U., Farber O., Kinzel A., Strahlentherapie und Onkologie . 2018,第Suppla1期

机译：Panova-3：具有吉西他滨的TTFIELDS和NAB-PACLITAXEL的III期试验，用于局部晚期胰腺腺癌的前线治疗
3. Prospective Phase I Trial of Concurrent Full Dose Gemcitabine/Nab-paclitaxel and Ablative Radiation Therapy for Borderline and Locally Advanced Pancreatic Cancer [J] . Kim H., Olsen J. R., Wang-Gillam A., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：治疗阶段I试验同期全剂量吉西他滨/赤紫外线和侧腹和局部晚期胰腺癌的烧蚀治疗
4. Changing the treatment paradigm: Ex vivo assessment of gemcitabine-eluting degradable polymeric fibres for the treatment of pancreatic cancer [C] . Simon Moulton, Amanda Zuzic, Samantha Wade, World biomaterials congress . 2016

机译：改变治疗范式：吉西他滨洗脱可降解聚合物纤维的离体评估，用于治疗胰腺癌
5. Formulation, Optimization and Efficacy of Gemcitabine Loaded Thermosensitive Liposomal Nanoparticles in the Treatment of Pancreatic Cancer [D] . Affram, Kevin Osei. 2018

机译：吉西他滨负载热敏脂质体纳米颗粒的制备，优化及疗效
6. Complete response of refractory mycosis fungoides to treatment of pancreatic cancer with combination gemcitabine and nab-paclitaxel: A possible new regimen for the treatment of advanced cutaneous T-cell lymphoma [O] . Michelle Pratt, Steven J. Glassman 2020

机译：难治性霉菌诱导对组合Gemcitabine和Nab-Paclitaxel治疗胰腺癌的完全反应：一种治疗晚期皮肤T细胞淋巴瘤的可能新的方案
7. OP2 Nab-paclitaxel in the treatment of advanced pancreatic cancer refractory to gemcitabine – Final results of a phase 2 trial [O] . de Lima Lopes G., Hosein P., Gomez C., 2011

机译：OP2 Nab-紫杉醇治疗难治性吉西他滨的晚期胰腺癌– 2期试验的最终结果

OP2 Nab-paclitaxel in the treatment of advanced pancreatic cancer refractory to gemcitabine - Final results of a phase 2 trial

著录项

相似文献

相关主题

期刊订阅